These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16990828)

  • 1. Narcolepsy and the hypocretin system--where motion meets emotion.
    Siegel JM; Boehmer LN
    Nat Clin Pract Neurol; 2006 Oct; 2(10):548-56. PubMed ID: 16990828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the development of therapeutics for narcolepsy.
    Black SW; Yamanaka A; Kilduff TS
    Prog Neurobiol; 2017 May; 152():89-113. PubMed ID: 26721620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.
    Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS
    J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in the diagnosis and treatment of narcolepsy-cataplexy syndrome].
    de Vicente Alvarez-Manzaneda EE
    Rev Neurol; 2008 May 1-15; 46(9):550-6. PubMed ID: 18446698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.
    Szabo ST; Thorpy MJ; Mayer G; Peever JH; Kilduff TS
    Sleep Med Rev; 2019 Feb; 43():23-36. PubMed ID: 30503715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin (orexin): role in normal behavior and neuropathology.
    Siegel JM
    Annu Rev Psychol; 2004; 55():125-48. PubMed ID: 14744212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep, sleep disorders and hypocretin (orexin).
    Mignot E
    Sleep Med; 2004 Jun; 5 Suppl 1():S2-8. PubMed ID: 15301991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
    Thannickal TC; Nienhuis R; Siegel JM
    Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced number of hypocretin neurons in human narcolepsy.
    Thannickal TC; Moore RY; Nienhuis R; Ramanathan L; Gulyani S; Aldrich M; Cornford M; Siegel JM
    Neuron; 2000 Sep; 27(3):469-74. PubMed ID: 11055430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.
    Kaur S; Thankachan S; Begum S; Liu M; Blanco-Centurion C; Shiromani PJ
    PLoS One; 2009 Jul; 4(7):e6346. PubMed ID: 19623260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sodium oxybate on hypocretin/orexin and locus coeruleus neurons.
    Wu MF; Thannickal TC; Li S; McGregor R; Lai YY; Siegel JM
    Sleep; 2023 Sep; 46(9):. PubMed ID: 37155728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcolepsy: clinical approach to etiology, diagnosis, and treatment.
    Koziorynska EI; Rodriguez AJ
    Rev Neurol Dis; 2011; 8(3-4):e97-106. PubMed ID: 22249574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic ablation of hypocretin neurons alters behavioral state transitions in zebrafish.
    Elbaz I; Yelin-Bekerman L; Nicenboim J; Vatine G; Appelbaum L
    J Neurosci; 2012 Sep; 32(37):12961-72. PubMed ID: 22973020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocretin/orexin, sleep and narcolepsy.
    Hungs M; Mignot E
    Bioessays; 2001 May; 23(5):397-408. PubMed ID: 11340621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.
    Tonon C; Franceschini C; Testa C; Manners DN; Poli F; Mostacci B; Mignot E; Montagna P; Barbiroli B; Lodi R; Plazzi G
    Brain Res Bull; 2009 Sep; 80(3):147-50. PubMed ID: 19463917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocretin (orexin) is critical in sustaining theta/gamma-rich waking behaviors that drive sleep need.
    Vassalli A; Franken P
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5464-E5473. PubMed ID: 28630298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.